| Literature DB >> 25742272 |
Alex Pauvolid-Corrêa1, Raquel Soares Juliano2, Zilca Campos2, Jason Velez3, Rita Maria Ribeiro Nogueira1, Nicholas Komar3.
Abstract
The Pantanal hosts diverse wildlife species and therefore is a hotspot for arbovirus studies in South America. A serosurvey for Mayaro virus (MAYV), eastern (EEEV), western (WEEV) and Venezuelan (VEEV) equine encephalitis viruses was conducted with 237 sheep, 87 free-ranging caimans and 748 equids, including 37 collected from a ranch where a neurologic disorder outbreak had been recently reported. Sera were tested for specific viral antibodies using plaque-reduction neutralisation test. From a total of 748 equids, of which 264 were immunised with vaccine composed of EEEV and WEEV and 484 had no history of immunisation, 10 (1.3%) were seropositive for MAYV and two (0.3%) for VEEV using criteria of a ≥ 4-fold antibody titre difference. Among the 484 equids without history of immunisation, 48 (9.9%) were seropositive for EEEV and four (0.8%) for WEEV using the same criteria. Among the sheep, five were sero- positive for equine encephalitis alphaviruses, with one (0.4%) for EEEV, one (0.4%) for WEEV and three (1.3%) for VEEV. Regarding free-ranging caimans, one (1.1%) and three (3.4%), respectively, had low titres for neutralising antibodies to VEEV and undetermined alphaviruses. The neurological disorder outbreak could not be linked to the alphaviruses tested. Our findings represent strong evidence that MAYV and all equine encephalitis alphaviruses circulated in the Pantanal.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25742272 PMCID: PMC4371226 DOI: 10.1590/0074-02760140383
Source DB: PubMed Journal: Mem Inst Oswaldo Cruz ISSN: 0074-0276 Impact factor: 2.743
Fig. 1subregions of Nhecolândia and Nabileque of the Pantanal where an alphavirus serosurvey was conducted in equids, sheep and free-ranging caimans in 2009, 2010 and 2011.
Results of 90% plaque-reduction neutralisation test (PRNT90) for alphaviruses in equids of Pantanal, Brazil
| Unvaccinated (n = 484) | Vaccinated (n = 264) | Total (n = 748) | ||||||
|---|---|---|---|---|---|---|---|---|
| ≥ 10 (%) | 4-fold greater criterion (%) | ≥ 10 (%) | 4-fold greater criterion (%) | ≥ 10 (%) | 4-fold greater criterion (%) | |||
| EEEV | 87 (18) | 48 (9.9) | 96 (36.4) | 47 (17.8) | 183 (24.5) | 95 (12.7) | ||
| WEEV | 8 (1.7) | 4 (0.8) | 42 (15.9) | 15 (5.7) | 50 (6.7) | 19 (2.5) | ||
| VEEV | 4 (0.8) | 1 (0.2) | 1 (0.4) | 1 (0.4) | 5 (0.7) | 2 (0.3) | ||
| MAYV | 36 (7.4) | 10 (2.1) | 8 (3) | 0 (0) | 44 (5.9) | 10 (1.3) | ||
| ALPHA | - | 50 (10.3) | - | 54 (20.4) | - | 104 (13.9) | ||
| NEG | - | 371 (76.7) | - | 147 (55.7) | - | 518 (69.3) | ||
ALPHA: undetermined alphavirus; EEEV: eastern equine encephalitis virus; MAYV: Mayaro virus; NEG: PRNT90 titre < 10 to all four alphaviruses; VEEV: Venezuelan equine encephalitis virus; WEEV: western equine encephalitis virus.
Titres of 90% plaque-reduction neutralisation test (PRNT90) for four alphaviruses among unvaccinated equids from Nhecolândia subregion seropositive to a determined alphavirus in the Pantanal, Brazil
| Equid ID | Age (years) | Ranch | Gender | Sampling date | MAYV | VEEV | EEEV | WEEV | Result |
|---|---|---|---|---|---|---|---|---|---|
| 757 | 7 | PJ | Mare | October/2009 | < 10 | < 10 | 160 | < 10 | EEEV |
| 764 | 11 | PJ | Mare | October/2009 | 10 | < 10 | 160 | < 10 | EEEV |
| 774 | 2 | PJ | Mare | October/2009 | < 10 | < 10 | 160 | < 10 | EEEV |
| 809 | UNK | PJ | Mare | October/2009 | 10 | < 10 | 160 | < 10 | EEEV |
| 328 | UNK | PH | Gelding | October/2009 | < 10 | < 10 | 20 | < 10 | EEEV |
| 451 | 5 | PN | Gelding | October/2009 | < 10 | < 10 | 20 | < 10 | EEEV |
| 513 | 6 | PS | Mule | October/2009 | < 10 | < 10 | 20 | < 10 | EEEV |
| 746 | 2 | PJ | Gelding | October/2009 | < 10 | < 10 | 20 | < 10 | EEEV |
| 755 | 8 | PJ | Mare | October/2009 | < 10 | < 10 | 20 | < 10 | EEEV |
| 773 | UNK | PJ | Mare | October/2009 | < 10 | < 10 | 20 | < 10 | EEEV |
| 785 | 4 | PJ | Mare | October/2009 | < 10 | < 10 | 20 | < 10 | EEEV |
| 399 | UNK | PP | Mare | October/2009 | < 10 | < 10 | 20 | < 10 | EEEV |
| 406 | UNK | PP | Mare | October/2009 | < 10 | < 10 | 20 | < 10 | EEEV |
| 700 | 12 | PJ | Gelding | October/2009 | < 10 | < 10 | 20 | < 10 | EEEV |
| 701 | UNK | PJ | Gelding | October/2009 | < 10 | < 10 | 20 | < 10 | EEEV |
| 703 | UNK | PJ | Gelding | October/2009 | < 10 | < 10 | 20 | < 10 | EEEV |
| 708 | 9 | PJ | Gelding | October/2009 | < 10 | < 10 | 20 | < 10 | EEEV |
| 714 | 11 | PJ | Gelding | October/2009 | < 10 | < 10 | 20 | < 10 | EEEV |
| 834 | 11 | PG | Mare | April/2010 | < 10 | < 10 | 20 | < 10 | EEEV |
| 835 | 8 | PG | Gelding | April/2010 | < 10 | < 10 | 20 | < 10 | EEEV |
| 840 | 7 | PG | Mare | April/2010 | < 10 | < 10 | 20 | < 10 | EEEV |
| 853 | UNK | PG | Mare | April/2010 | < 10 | < 10 | 20 | < 10 | EEEV |
| 725 | 11 | PJ | Gelding | October/2009 | < 10 | < 10 | 320 | < 10 | EEEV |
| 459 | 5 | PN | Gelding | October/2009 | < 10 | < 10 | 40 | < 10 | EEEV |
| 465 | UNK | PN | Gelding | October/2009 | 10 | < 10 | 40 | < 10 | EEEV |
| 511 | 4 | PS | Donkey | October/2009 | < 10 | < 10 | 40 | < 10 | EEEV |
| 761 | 15 | PJ | Mare | October/2009 | < 10 | < 10 | 40 | < 10 | EEEV |
| 766 | 21 | PJ | Mare | October/2009 | 10 | < 10 | 40 | < 10 | EEEV |
| 811 | 12 | PJ | Mare | October/2009 | < 10 | < 10 | 40 | < 10 | EEEV |
| 413 | UNK | PP | Gelding | October/2009 | < 10 | < 10 | 40 | < 10 | EEEV |
| 712 | UNK | PJ | Gelding | October/2009 | < 10 | < 10 | 40 | < 10 | EEEV |
| 838 | 7 | PG | Mare | April/2010 | < 10 | < 10 | 40 | < 10 | EEEV |
| 880 | UNK | PG | Gelding | April/2010 | < 10 | < 10 | 40 | < 10 | EEEV |
| 882 | UNK | PG | Gelding | April/2010 | < 10 | < 10 | 40 | < 10 | EEEV |
| 427 | UNK | PN | Mare | October/2009 | 10 | < 10 | 80 | < 10 | EEEV |
| 445 | 2 | PN | Stallion | October/2009 | < 10 | < 10 | 80 | < 10 | EEEV |
| 762 | 6 | PJ | Mare | October/2009 | < 10 | < 10 | 80 | < 10 | EEEV |
| 779 | 11 | PJ | Mare | October/2009 | < 10 | < 10 | 80 | < 10 | EEEV |
| 801 | 11 | PJ | Mare | October/2009 | 10 | < 10 | 80 | < 10 | EEEV |
| 802 | 14 | PJ | Mare | October/2009 | < 10 | < 10 | 80 | < 10 | EEEV |
| 693 | 11 | PJ | Gelding | October/2009 | 20 | < 10 | 80 | < 10 | EEEV |
| 699 | UNK | PJ | Gelding | October/2009 | 10 | < 10 | 80 | < 10 | EEEV |
| 702 | 11 | PJ | Gelding | October/2009 | 10 | < 10 | 80 | < 10 | EEEV |
| 717 | 12 | PJ | Gelding | October/2009 | < 10 | < 10 | 80 | < 10 | EEEV |
| 727 | 12 | PJ | Gelding | October/2009 | 10 | < 10 | 80 | < 10 | EEEV |
| 849 | 5 | PG | Mare | April/2010 | < 10 | < 10 | 80 | < 10 | EEEV |
| 879 | 10 | PG | Gelding | April/2010 | < 10 | < 10 | 80 | < 10 | EEEV |
| 1077 | UNK | PJ | Gelding | October/2009 | < 10 | < 10 | 160 | 10 | EEEV |
| 363 | UNK | PM | Donkey | October/2009 | 20 | < 10 | < 10 | < 10 | MAYV |
| 368 | UNK | PM | Gelding | October/2009 | 20 | < 10 | < 10 | < 10 | MAYV |
| 370 | UNK | PM | Gelding | October/2009 | 20 | < 10 | < 10 | < 10 | MAYV |
| 375 | UNK | PM | Stallion | October/2009 | 20 | < 10 | < 10 | < 10 | MAYV |
| 436 | UNK | PN | Mare | October/2009 | 20 | < 10 | < 10 | < 10 | MAYV |
| 806 | 17 | PJ | Mare | October/2009 | 40 | < 10 | < 10 | < 10 | MAYV |
| 694 | 6 | PJ | Gelding | October/2009 | 20 | < 10 | < 10 | < 10 | MAYV |
| 719 | 11 | PJ | Gelding | October/2009 | 40 | < 10 | < 10 | < 10 | MAYV |
| 852 | UNK | PG | Mare | April/2010 | 40 | < 10 | < 10 | < 10 | MAYV |
| 433 | UNK | PN | Mare | October/2009 | 40 | < 10 | 10 | < 10 | MAYV |
| 493 | 1 | PS | Mare | October/2009 | < 10 | 20 | < 10 | < 10 | VEEV |
| 805 | 12 | PJ | Mare | October/2009 | < 10 | < 10 | 20 | 160 | WEEV |
| 722 | 11 | PJ | Gelding | October/2009 | < 10 | < 10 | < 10 | 20 | WEEV |
| 819 | UNK | PG | Mare | April/2010 | < 10 | < 10 | < 10 | 20 | WEEV |
| 935 | UNK | PD | Gelding | September/2010 | < 10 | < 10 | < 10 | 20 | WEEV |
a: all the equids were healthy, except for this individual which presented with a neurological disorder; EEEV: eastern equine encephalitis virus; MAYV: Mayaro virus; UNK: unknown; VEEV: Venezuelan equine encephalitis virus; WEEV: western equine encephalitis virus.
Fig. 2statistically significant seroprevalence trends by age among unvaccinated equids from Pantanal with known age (n = 212). ALPHA: undetermined alphavirus; EEEV: eastern equine encephalitis virus; NEG: 90% plaque-reduction neutralisation test titre < 10 to all four alphaviruses.
Results of 90% plaque-reduction neutralisation test (PRNT90) for alphaviruses in caimans and sheep of southern Pantanal, Brazil
| Free-ranging caimans (n = 87) | Sheep (n = 237) | ||||
|---|---|---|---|---|---|
| ≥ 10 (%) | 4-fold greater criterion (%) | ≥ 10 (%) | 4-fold greater criterion (%) | ||
| EEEV | 0 (0) | 0 (0) | 2 (0.8) | 1 (0.4) | |
| WEEV | 1 (1.1) | 0 (0) | 1 (0.4) | 1 (0.4) | |
| VEEV | 1 (1.1) | 1 (1.1) | 3 (1.3) | 3 (1.3) | |
| MAYV | 2 (2.2) | 0 (0) | 3 (1.3) | 0 (0) | |
| ALPHA | - | 3 (3.4) | - | 4 (1.7) | |
| NEG | - | 83 (95.4) | - | 228 (96.2) | |
ALPHA: undetermined alphavirus; EEEV: eastern equine encephalitis virus; MAYV: Mayaro virus; NEG: PRNT90 titre < 10 to all four alphaviruses; VEEV: Venezuelan equine encephalitis virus; WEEV: western equine encephalitis virus.